Riverside Partners, a middle market private equity firm focusing on growth-oriented companies in the healthcare and technology industries, has closed its $406m Riverside Fund IV, L.P.
Fund IV, launched in April 2009 with a target of $325m, was significantly oversubscribed. It received support from almost all existing institutional investors while also attracting a number of new partners including state and corporate pension plans, foundations, consultants, and European investors.
The new fund will continue Riverside’s focus on control investments in established lower middle market healthcare and technology companies.
Atlantic-Pacific Capital acted as the exclusive global placement agent and financial advisor.